Safety and pharmacokinetics of blonanserin in healthy Chinese subjects
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2015
At a glance
- Drugs Blonanserin (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 23 Oct 2015 Location is assumed.
- 23 Oct 2015 New trial record
- 08 Jan 2014 Results published in the Clinical drug investigation.